CET Cancer Center, High Dose Rate (hdr) Brachytherapy Specialist with 25 years of experience
Toll Free 877-238-1437

Contact Us

E-mail This Page


Breast Brachytherapy

( High Dose Rate Brachytherapy for Breast Cancer )


Back to Top1. Introduction


Over the past two decades, breast conserving treatment, consisting of lumpectomy and external beam radiotherapy, has become a standard treatment option for patients with early stage cancer. It has been demonstrated to offer similar local control and survival results compared with mastectomy, while providing acceptable cosmetic outcome, and less emotional trauma. However, the primary disadvantages are 6 to 7 weeks of external beam treatment and potential side effects to the adjacent organs such as the underlying lungs and scatter radiation dose to the opposite breast.
Recurrence rates followinglumpectomy and whole breast external beam radiotherapy are approximately 10%. The majority of recurrences are in the vicinity of the lumpectomy site. The potential to reduce breast recurrence rates lies in maximizing the radiation dose to the breast tissue surrounding the lumpectomy site, which is the tissue most likely to harbor residual microscopic disease. Attempts to increase the radiation dose using external beam radiotherapy have resulted in increasing the side effects such as moderate to severe skin reactions (desquamations), and excessive doses to the underlying ribs and lung. The best method of increasing the dose to the lumpectomy site while minimizing the dose to the normal structures is HDR brachytherapy.

Back to TopTable of Content

  1. Introduction
  2. Advantage of HDR Brachytherapy
  3. Surgery and HDR Procedure
  4. Computer Dosimetry
  5. Cosmetic Result

Back to Top2. The Advantages of HDR Brachytherapy

  1. The overall treatment time is reduced to 5 to 7 days compared to a 6 to 7 week course of external beam radiotherapy.
  2. Breast brachytherapy delivers a precisely targeted dose to the tissues most at risk for recurrence, increasing the likelihood of tumor control.
  3. Reduces radiation dose to the lungs and opposite breast
  4. Reduces radiation dose to the breast outside the brachytherapy treatment volume, avoiding potential long term adverse cosmetic side effects associated with whole breast external beam therapy, such as fibrosis and skin reactions.
  5. Breast brachytherapy causes no delays in other treatments such as chemotherapy.
  6. Conserve your breast and yield excellent cosmetic result .

Back to Top3. Surgery and HDR Procedure

The brachytherapy implant can be done at the time of lumpectomy or later, after the lumpectomy incision has healed. The patient is placed under general anesthesia. The brachytherapy physician places rows of thin hollow tubes, the treatment catheters, to encompass the tumor bed plus generous margins. These catheters will later hold the radioactive source. The catheters are left in place with the catheter ends protruding through the skin for the duration of the treatment course, which is about five days. On the first day of treatment, radiographic or CT images of the implant are obtained for treatment planning purposes. After the radiation dose plan is reviewed and approved by the physician, the treatments can begin.

Fig 1: Breast Implants
The protruding ends of the plastic catheters are connected via longer, transfer tubes to the treatment unit, called the afterloader, that contains the tiny radioactive source. The tiny (1mmx3mm) source is welded to the tip of a flexible stainless steel cable that travels in and out of the treatment catheters. The source steps through each of the catheters, stopping every 5mm to deliver the required radiation dose. After the treatment is delivered, the source retracts into the afterloader, the treatment catheters are disconnected from the transfer tubes, the nurses cover the implant with dressings and the patient goes home. The time the source spends in the catheters is about 10 minutes.
The breast is treated twice a day for five days, for a total of 10 treatments (also called "fractions"). After the last treatment, the physician removes the catheters. The catheters easily slip out of the breast with minimal bleeding. Antibiotic ointment is applied to the catheter insertion sites. The patient is instructed on skin care and given an appointment to return for a follow-up visit.

Back to Top4. Computer Dosimetry

Fig 2: 3D computer simulation showing radiation dose cloud.
The image on the left is the 3-D representation of the implant catheters (light blue), the 100% radiation dose "cloud" (blue) the underlying lung (yellow), and the skin (transparent yellow). The image on the right is a transverse CT cut showing the levels of radiation dose. Note how the dosimetrist has shaped the treatment volume to avoid the underlying ribs and lung and keep the skin dose at 50% of the prescription dose to avoid skin reactions.

Back to Top5. Cosmetic Result

Fig 3: 2 months after treatment. Fig 4: 10 months after treatment. Fig 5: 3 years after treatment, achieve excellent cosmetic result.










Back to TopGeneral Frequently Asked Questions


1. How does radiation kill cancer?


Cancer is made of abnormal cells that tend to grow without control. Cancer DNA is more sensitive to radiation than are normal cells, so radiation kills cancer directly or when the cells attempt to multiply while normal tissue in the region is able to repair and recover.


2. What is Brachytherapy?


The prefix "brachy" is the Greek word for "short" distance. Brachytherapy is a form of internal radiation treatment where radioactive sources are placed on or into cancer tissues. There are two kinds of brachytherapy. The radiation sources may be inserted either permanently or temporarily. The two most common forms of treatment are low dose rate (LDR) permanent seeds for prostate cancer and high dose rate (HDR) temporary brachytherapy, that can be used for prostate, gynecologic, breast, head and neck, lung, esophageal, bile duct, anorectal, sarcoma, and other cancers.

3. What is high dose rate (HDR) Brachytherapy?


High dose rate (HDR) is a technically advanced form of brachytherapy. A high intensity radiation source is delivered with millimeter precision under computer guidance directly into the tumor killing it from the inside out while avoiding injury to surrounding normal healthy tissue. For a more in depth explanation please go to understanding HDR Brachytherapy page.

4. What are the advantages of HDR Brachytherapy?

  • Preservation of organ structure and function
  • Improved accuracy and precision of radiation dose delivery
  • Knowledge of radiation dose distribution before treatment is given
  • Ability to shape the radiation dose to fit the tumor
  • Fewer side effects
  • No radiation source (seeds) migration into other organs
  • No radiation exposure to other persons
  • The treatment course is days rather than weeks to months (as required for permanent seeds or external beam)
  • Excellent coverage of possible microscopic extension of cancer
  • Minimizes areas of radiation overdose (hot spots) or underdose (cold spots)
  • Organ motion (target movement) is not a problem for HDR as it is with external beam
  • Effective treatment for cancer recurrence (termed "salvage" therapy)

5. How successful is HDR Brachytherapy?


HDR Brachytherapy is proven to be effective for the treatment of local disease in many forms of cancer including prostate, gynecological, breast, head and neck, esophagus, lung, anorectal, bile duct, sarcoma, and other primary cancer or localized metastasis as reported in the medical literature. CET's publication on prostate cancer, for example has demonstrated 90% 10-year tumor control. Success rates for other tumors vary according to the type and stage of cancer being treated.

6. How many treatments has CET administered?


As of 8/31/2005, CET has performed 8,023 HDR implants and delivered 16,464 HDR treatments. Please see our treatment statistics for further details.

7. Why is HDR less well known than other forms of cancer treatment?


HDR Brachytherapy is a relatively new form of advance radiation technology. Fewer physicians have been trained to perform HDR procedures compared to seed implants or external beam radiation. Few centers, other than CET have been dedicated to the development of HDR brachytherapy to its full potential. Dr. Demanes has devoted his career to the advancement of brachytherapy and has pioneered the use of HDR and established CET as a center of excellence with specially trained and experienced staff and physicians.

8. Why should I select CET?

Please see CET Advantage for more information.

Back to TopAbout Us

Membership and affiliations

American Society for Therapeutic Radiology And Oncology
Chair - Health Policy and Economics Practice Management Subcommittee,
Chair - Regulatory Subcommittee, Member - Health Policy and Economic Committee,
Member - Health Policy and Economics Code Development and Valuation Subcommittee,
Member - Code Utilization and Application Subcommittee.

American Brachytherapy Society
Chair
- Socioeconomic Committee.

American College of Radiation Oncology
President - 2005 to 2006